Cyclerion Therapeutics Inc (CYCN)
3.218
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
Cyclerion Therapeutics Shares Outstanding: 2.710M for Feb. 29, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 29, 2024 | 2.710M |
December 31, 2023 | 2.474M |
November 09, 2023 | 2.445M |
September 30, 2023 | 2.445M |
July 24, 2023 | 2.411M |
June 30, 2023 | 2.408M |
June 15, 2023 | 2.408M |
May 19, 2023 | 2.401M |
May 16, 2023 | 2.176M |
May 01, 2023 | 2.176M |
March 31, 2023 | 2.176M |
March 19, 2023 | 2.176M |
February 28, 2023 | 2.176M |
December 31, 2022 | 2.176M |
November 01, 2022 | 2.175M |
September 30, 2022 | 2.175M |
August 05, 2022 | 2.174M |
June 30, 2022 | 2.174M |
May 02, 2022 | 2.172M |
March 31, 2022 | 2.172M |
February 22, 2022 | 2.170M |
December 31, 2021 | 2.170M |
November 05, 2021 | 2.166M |
September 30, 2021 | 2.166M |
July 27, 2021 | 2.164M |
Date | Value |
---|---|
June 30, 2021 | 2.164M |
June 07, 2021 | 2.021M |
June 03, 2021 | 1.734M |
April 27, 2021 | 1.707M |
March 31, 2021 | 1.706M |
March 28, 2021 | 1.706M |
February 18, 2021 | 1.703M |
December 31, 2020 | 1.702M |
November 03, 2020 | 1.698M |
September 30, 2020 | 1.698M |
July 31, 2020 | 1.696M |
July 29, 2020 | 1.696M |
July 28, 2020 | 1.393M |
July 23, 2020 | 1.393M |
June 30, 2020 | 1.393M |
May 01, 2020 | 1.388M |
March 31, 2020 | 1.388M |
March 23, 2020 | 1.388M |
March 05, 2020 | 1.388M |
December 31, 2019 | 1.380M |
November 06, 2019 | 1.373M |
September 30, 2019 | 1.373M |
August 12, 2019 | 1.371M |
June 30, 2019 | 1.371M |
May 08, 2019 | 1.370M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
1.370M
Minimum
May 08 2019
2.710M
Maximum
Feb 29 2024
1.917M
Average
2.164M
Median
Jun 30 2021
Shares Outstanding Benchmarks
Eli Lilly and Co | 950.77M |
iBio Inc | 3.484M |
AbbVie Inc | 1.766B |
Agile Therapeutics Inc | 6.856M |
NovaBay Pharmaceuticals Inc | 30.10M |